Vizora日本語

ADR Biomedical HoldingsADR Biomedical Holdings Inc.3750東証スタンダード情報・通信業FY ending Mar 2026, consolidated, J-GAAP

ADR Biomedical Holdings FY ending Mar 2022 results

About 81% of ADR Biomedical Holdings's sales come from Real Asset, with Medical making up much of the rest.

It lost about ¥35 for every ¥100 of sales at the operating level.

Revenue changed -3.8% from the prior year.

What changed from last year

FY ending Mar 2021 → FY ending Mar 2022

Revenue
-3.8%¥1.39B → ¥1.34B
Gross profit
+13.0%¥760.3M → ¥859.2M
Operating income
Loss-¥731.7M → -¥462.3M
Net income attributable to owners
Loss-¥831.9M → -¥77.6M
Operating cash flow
Loss-¥82.9M → -¥187.8M
Free cash flow
Loss-¥98.9M → -¥367.8M

Where the money goes

FY ending Mar 2021 → FY ending Mar 2022

Where ¥100 of sales goes

For every ¥100 ADR Biomedical Holdings sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥36
SG&A
¥99
Operating loss
¥35
Net loss
¥6

Annual margin trends

Gross margin64.3%
FY ending Mar 2020: 64.1%64.1%FY ending Mar 2021: 54.8%54.8%FY ending Mar 2022: 64.3%64.3%FY20FY21FY22
Operating margin-34.6%
FY ending Mar 2020: -10.9%-10.9%FY ending Mar 2021: -52.7%-52.7%FY ending Mar 2022: -34.6%-34.6%FY20FY21FY22
Net margin-5.8%
FY ending Mar 2020: 27.1%27.1%FY ending Mar 2021: -59.9%-59.9%FY ending Mar 2022: -5.8%-5.8%FY20FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2022
  • Real Asset¥1.08B
    81%
    Op. margin -14.5%
  • Medical¥257.1M
    19%
    Op. margin -61.3%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第22期(2025/04/01－2026/03/31)

    ID S100YLDW2026-06-26Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第21期(2024/04/01－2025/03/31)

    ID S100WZTN2025-11-07Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2023/04/01－2024/03/31)

    ID S100TUF62024-06-26Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第19期(2022/04/01－2023/03/31)

    ID S100RS4G2023-08-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第18期(令和3年4月1日－令和4年3月31日)

    ID S100OEC72022-06-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和2年4月1日－令和3年3月31日)

    ID S100LPPV2021-06-24Open

Extracted from XBRL: 49 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image